Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion type Assertion NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_head.
- NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion description "[GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_provenance.
- NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion evidence source_evidence_literature NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_provenance.
- NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion SIO_000772 19141695 NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_provenance.
- NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion wasDerivedFrom befree-20150227 NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_provenance.
- NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_assertion wasGeneratedBy ECO_0000203 NP425299.RAYerLIIMw9Yt3QiqI-KB_M2v_JPupH4f__nvI09yltfA130_provenance.